3rd Quarter - Amendment

BROWNSTEIN HYATT FARBER SCHRECK, LLP for BAXTER HEALTHCARE CORPORATION

Firm
Client
Income
$30,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 19, 2017 $30,000 Replaced
3rd Quarter - Amendment (this page) Oct 5, 2019 $30,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Corporate tax issues, including deferral and device tax Tax reform Issues related to the border adjustment tax

LobbyistCovered position, as disclosed
ALEXANDER DAHL —
LORI HARJU —
MICHAEL B LEVY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Healthcare reform In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act S. 934/H.R. 2430 - FDA Reauthorization Act of 2017

LobbyistCovered position, as disclosed
CATE MCCANLESS BLANKENBURG —
LAURA JOHNSON BOLLIER —
ALEXANDER DAHL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 934 (115th), H.R. 2430 (115th), H.R. 1245 (115th)

Medicare/Medicaid MMM

Funding issues for Medicare Part B 340 B drug discount program

LobbyistCovered position, as disclosed
CATE MCCANLESS BLANKENBURG —
LAURA JOHNSON BOLLIER —
ALEXANDER DAHL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.